Recursive self-improvement is central to arguments about transformative AI risk, David Stone writes in this guest column.

The top model developers except one all have one thing in common: they are all currently founder-led companies. Alphabet is ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...